Intra-arterial neoadjuvant chemotherapy followed by radical surgery and radiotherapy for stage IIb cervical carcinoma

Anticancer Research

Volumn 17, Issue 5 B, 1997, Pages 3751-3755

  Fujiwaki, Ritsuto ^a   Iida, Kohji ^a   Ohnishi, Yuichi ^a   Watanabe, Yumi ^a   Ryuko, Kanji ^a   Takahashi, Kentaro ^a   Miyazaki, Kohji ^a  

^a SHIMANE UNIVERSITY   (Japan)

Author keywords

Cervical carcinoma; Intra arterial neoadjuvant chemotherapy; Stage IIb; Survival

Indexed keywords

CISPLATIN; DOXORUBICIN; PEPLEOMYCIN; PROTEIN P53;

ADENOCARCINOMA; ADJUVANT CHEMOTHERAPY; ADULT; AGE; ALOPECIA; ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CELL DIFFERENTIATION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; LEUKOPENIA; LYMPH NODE METASTASIS; MULTIMODALITY CANCER THERAPY; NAUSEA; PELVIS LYMPHADENECTOMY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RADICAL HYSTERECTOMY; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME; THROMBOCYTOPENIA; UTERINE CERVIX CARCINOMA; VOMITING;

ADULT; AGED; ANALYSIS OF VARIANCE; ANTINEOPLASTIC AGENTS; CHEMOTHERAPY, ADJUVANT; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; MIDDLE AGED; NEOPLASM STAGING; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; UTERINE CERVICAL NEOPLASMS;

EID: 0031468379     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Perez CA, Kurman RJ, Stehman FB et al: Principles and practice of gynecologic oncology. Hoskins WJ, Peres CA, Young RC. Philadelphia, JB Lippincott. 1992, Uterine cervix, 591-662.
2. Randall ME, Constable WC, Hahn S et al: Results of radiotherapeutic management of carcinoma of the cervix with emphasis on influence of histologic classification. Cancer 62: 48-53, 1988.
3. Grigsby PW, Perez CA, Kuske RR et al: Adenocarcinoma of the uterine cervix: Lack of evidence for a poor prognosis. Radiother Oncol 12: 289-296, 1988.
4. Lee YN, Wang KL, Lin MH et al: Radical hysterectomy with pelvic lymph node dissection for treatment of cervical cancer: A clinical review of 954 cases. Gynecol Oncol 32: 135-142, 1989.
5. Kohno Y, Iwanari O, Kitao M: Prognostic importance of histologic vascular density in cervical cancer treated with hypertensive intraarterial chemotherapy. Cancer 72: 2394-2400, 1993.
6. Hata K, Hata T, Manabe A et al: Transvaginal doppler ultrasound assessment of intratumoral hemodynamic change before and during hypertensive intra-arterial chemotherapy for uterine cancer. Obstet Gynecol 80: 801-804, 1992.
7. Park SY, Kim BG, Kim JH et al: Phase I/II study of neoadjuvant intraarterial chemotherapy with mitomycin-C, vincristine, and cisplatin in patients with stage IIb bulky cervical carcinoma. Cancer 76: 814-823, 1995.
8. Kigawa J, Minagawa Y, Ishihara H et al: The role of neoadjuvant intraarterial infusion chemotherapy with cisplatin and bleomycin for locally advanced cervical cancer. Am J Clin Oncol 19: 255-259, 1996.
9. Scarabelli C, Tumolo S, Paoli AD et al: Intermittent pelvic arterial infusion with peptichemio, doxorubicin, and cisplatin for locally advanced and recurrent carcinoma of the uterine cervix. Cancer 60: 25-30, 1987.
10. Rettenmier MA, Moran MF, Ramsinghani NF et al: Treatment of advanced and recurrent squamous carcinoma of the uterine cervix with constant intraarterial infusion of cisplatin. Cancer 61: 1301-1303, 1988.
11. Patton TJ, Kavanagh JJ, Deldos L et al: Five-year survival in patients given intra-arterial chemotherapy prior to radiotherapy for advanced squamous carcinoma of the cervix and vagina. Gynecol Oncol 42: 54-59, 1991.
12. Panici BP, Greggi S, Scambia G et al: Locally advanced cervical adenocarcinoma: Is there a place for chemo-surgical treatment ? Gynecol Oncol 61: 44-49, 1996.
13. Panici BP, Scambia G, Baiocchi G et al: Neoadjuvant chemotherapy and radical surgery in locally advanced cervical cancer. Cancer 67: 372-379, 1991.
14. Kumar L, Kaushal M, Biswal BM et al: Chemotherapy followed by radiotherapy versus radiotherapy alone in locally advanced cervical cancer: a randomized study. Gynecol Oncol 54: 307-315, 1994.
15. Sardi J, Sananes C, Giaroli A et al: Neoadjuvant chemotherapy in locally advanced carcinoma of the cervix uteri. Gynecol Oncol 38: 486-493, 1990.
16. Namkoong SE, Park JS, Kim JW et al: Comparative study of the patients with locally advanced stage I and II cervical cancer treated by radical surgery with and without preoperative adjuvant chemotherapy. Gynecol Oncol 59: 136-142, 1995.
17. Kim DS, Moon H, Kim KT et al: Two-year survival: preoperative adjuvant chemotherapy in the treatment of cervical cancer stage Ib and II with bulky tumor. Gynecol Oncol 33: 225-230, 1989.
18. Kim SJ: Multitreatment for locally advanced stage IB, IIA, IIB patients of cervical cancer. Int J Gynecol Obstet 49: S49-S57, 1995.
19. Giaroli A, Sananes C, Sardi JE et al: Lymph node metastasis in carcinoma of the cervix uteri: response to neoadjuvant chemotherapy and its impact on survival. Gynecol Oncol 39: 34-39, 1990.
20. Dottino PR, Plaxe SC, Beddoe AM et al: Induction chemotherapy followed by radical surgery in cervical cancer. Gynecol Oncol 40: 7-11. 1991.
21. Scamhia G, Panici BP, Amoroso FM et al: Squamous cell carcinoma antigen: prognostic significance and role in monitoring of neoadjuvant chemotherapy response in cervical cancer. J Clin Oncol 12: 2309-2316, 1994.
22. Fontanelli R, Spatti G, Zunino RF et al: A preoperative single course of high dose cisplatin and bleomycin with glutathione protection in bulky stage IB/II carcinoma of the cervix. Ann Oncol 3: 117-121, 1992.
23. Lambkin HA, Mothersill CM, Kelehan P: Variations in immunohistochemical detection of p53 protein overexpression in cervical carcinomas with different antibodies and methods of detection. J Pathol 172: 13-18, 1994.
24. WHO: Handobook for reporting results of cancer treatment, WHO offset publication no. 48. Geneva: WHO, 1979.
25. Hickey K, Grehan D, Reid IM et al: Expression of epidermoid growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemotherapy. Cancer 74: 1693-1698, 1994.
26. Sarkis AS, Bajorin DF, Reuter VE et al: Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVAC. J Clin Oncol 13: 1984-1990, 1995.
27. Fujiwaki R, Takahashi K, Kitao M: Decrease in tumor volume and histologie response to intraarterial neoadjuvant chemotherapy in patients with cervical and endometrial adenocarcinoma. Gynecol Oncol 65: 258-264, 1997.